MedTrace Logo

Influence of FFR on the Clinical Outcome After Percutaneous Coronary Intervention

NCT01873560 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1250

Last updated 2023-09-28

No results posted yet for this study

Summary

Fractional flow reserve (FFR) is a physiologic index for the determination of ischemia-causing coronary stenosis as well as drug eluting stent (DES) optimization, even multiple anatomic imaging parameters have been widely used in clinical practice for the assessment of optimal stent procedure. Prognostic value of post-stent FFR (FFRpost) have been rarely evaluated in patient treated with 2nd generation DES. This multicentre, prospective registry was aimed to evaluate the influence of physiologic parameters on the clinical outcome after 2nd generation DES implantation.

Conditions

  • Coronary Disease

Sponsors & Collaborators

  • Seoul National University Hospital

    collaborator OTHER

  • Keimyung University Dongsan Medical Center

    collaborator OTHER

  • Ulsan University Hospital

    collaborator OTHER

  • Busan Veterans General Hospital

    collaborator UNKNOWN

  • Samsung Medical Center

    collaborator OTHER

  • Sejong General Hospital

    collaborator OTHER

  • Tokyo Medical University

    collaborator OTHER

  • Gifu Heart Center

    collaborator OTHER

  • Japanese Red Cross Kyoto Daini Hospital

    collaborator UNKNOWN

  • Inje University

    lead OTHER

Principal Investigators

  • Joon Hyung Doh, MD, PhD · Inje Univesity Ilsan Paik Hospital

  • Bon-Kwon Koo · Seoul National University Hospital

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2016-06-30
Completion
2016-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01873560 on ClinicalTrials.gov